How AI-enabled CCTA assessments help cardiologists and radiologists fight back against plaque
Coronary CT angiography (CCTA) continues to be one of the biggest stories in both cardiology and radiology. These noninvasive imaging tests have been helping clinicians for years now, but advanced artificial intelligence (AI) technologies and improved Medicare reimbursements have helped take their value to a whole other level.
Why, exactly, has CCTA been such a game-changer? What can AI-powered CCTA software tell care teams about a patient’s coronary plaques? Tune in to a new webinar from Cardiovascular Business and Heartflow to learn more.
Paul Cremer, MD, MS, and Bradley Allen, MD, MS, two cardiac imaging specialists with Northwestern Feinberg School of Medicine, will be sharing their personal experience with CCTA and share recommendations for building a collaborative radiology-cardiology plaque analysis program. In addition, the two specialists will review case studies highlighting how the worlds of cardiology and radiology can work together to help diagnose, treat and manage patients with suspected coronary artery disease.
Plaque Analysis image courtesy of Heartflow.
This webinar was developed with a large audience in mind, including general cardiologists, interventional cardiologists, radiologists, cardiovascular imaging specialists, vice presidents, administrators, cath lab directors, and CT technologists. The presentation is free and will be followed by a live Q&A session.
The webinar, “From Data to Decisions: How Quantitative Plaque Analysis is Reshaping the CAD Care Pathway,” is scheduled for Wednesday, Nov. 18 at 3 ET. Click here to register or learn more.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.